Southend residents face a stark health disparity as they are 'left behind' in the race for Mounjaro, a revolutionary weight loss jab. While approximately 3.4 million people nationwide meet the eligibility criteria for this drug, the NHS plans to treat a mere 220,000 individuals over a three-year period. This disparity is further exacerbated by a financial incentive for GP surgeries: a £3,000 bonus for prescribing the drug. However, the reality on the ground tells a different story. A typical GP practice serving 6,000 patients will have fewer than 20 individuals qualifying for the drug, and the funding for the first year is expected to cover only a fraction of that number. The situation is particularly dire in Southend, where the Liberal Democrats highlight some of the most pronounced health divides in the country, with a staggering 10.5-year gap in male life expectancy between the most and least affluent areas. Obesity, a key contributing factor to the health divide, is a pressing issue for many residents, yet the cost of private healthcare or prescriptions, which can range from £160 to £310 per month, remains a significant barrier to access.
